Sodium level on admission and in-hospital outcomes of STEMI patients treated with primary angioplasty: The ANIN Myocardial Infarction Registry

Medical Science Monitor

Volumn 15, Issue 9, 2009, Pages

  Klopotowski, Mariusz ^a   Kruk, Mariusz ^a   Przyluski, Jakub ^a   Kalinczuk, Lukasz ^a   Pregowski, Jerzy ^a   Bekta, Pawel ^a   Malek, Lukasz A ^a   Kepka, Cezary ^a   Ciszewski, Andrzej ^a   Chmielak, Zbigniew ^a   Demkow, Marcin ^a   Karcz, Maciej ^a   Witkowski, Adam ^a   Ruzyllo, Witold ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Angioplasty; Outcome; Primary; Sodium

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CATECHOLAMINE; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; SODIUM;

ADULT; ANGIOPLASTY; ARTICLE; BLOOD TRANSFUSION; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; CORONARY STENT; FEMALE; HAZARD RATIO; HEART FAILURE; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPONATREMIA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORTALITY; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

AGED; ANGIOPLASTY; HOSPITAL MORTALITY; HUMANS; HYPONATREMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; REGISTRIES; SODIUM; TREATMENT OUTCOME;

EID: 70349908138     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Schrier RW: Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol, 2006; 17: 1820-1832
2. De Luca L, Klein L, Udelson JE et al: Hyponatremia in patients with heart failure. Am J Cardiol, 2005; 96: 19L-23L
3. KleinL, O'Connor CM, Leimberger JD et al: Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbation of Chronic Heart Failure (OPTIME-CHF) study. Circulation, 2005; 111: 2454-2460
4. Goldberg A, Hammerman H, Petcherski S et al: Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction. Am J Med, 2004; 117: 242-248 (Pubitemid 39092717)
5. Singla I, Zahid M, Good CB et al: Effect of hyponatremia (<135 mEq/L) on outcome in patients with non-ST-elevation acute coronary syndrome. Am J Cardiol, 2007; 100: 406-408 (Pubitemid 47094689)
6. Gheorghiade M, Abraham WT, Albert NM et al: Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZEHF registry. Eur Heart J, 2007; 28: 980-988 (Pubitemid 47343897)
7. Alpert JS, Thygesen K, Antman E, Bassand JP: Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for redefinition of myocardial infarction. J Am Coll Cardiol, 2000; 36: 959-969 (Pubitemid 30681627)
8. Rose BD, Post TW: Hypoosmolal states - hyponatremia. In: Clinical physiology of acid-base and electrolyte Disorders. New York: McGraw- Hill, 2001; 696-745
9. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002; 39(Suppl.1): S1-S266
10. Zijlstra F, Hoorntje JCA, De Boer MJ et al: Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med, 1999; 341: 1413-1419 (Pubitemid 29513456)
11. Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet, 2003; 361: 13-20 (Pubitemid 36050955)
12. Goldberg A, Hammerman H, Petcherski S et al: Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction. Arch Intern Med, 2006; 166: 781-786
13. Flear CT, Hilton P: Hyponatremia and severity and outcome of myocardial infarction. BMJ, 1979; 1: 1242-1246 (Pubitemid 9176677)
14. Lee CT, Guo HR, Chen JB: Hyponatremia in the emergency department. Am J Emerg Med, 2000; 18: 264-268
15. Tavazzi L, Maggioni AP,Lucci D et al: Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J, 2006; 27: 1207-1215 (Pubitemid 43752391)
16. Marenzi G, Moltrasio M, Assanelli E et al: Impact of cardiac and renal dysfunction on in-hospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J, 2007; 153: 755-762 (Pubitemid 46602147)
17. Schaller MD, Nussberger J, Feihl F et al: Clinical and hemodynamic correlates of elevated plasma arginine vasopressin after acute myocardial infarction. Am J Cardiol, 1987; 60: 1178-1180
18. Beukhof CM, Hoorn EJ, Lindermans J, Zietse R: Novel risk factor for hospital-acquired hyponatremia: a matched case-control study. Clin Endocrinol (Oxf), 2007; 66: 367-372 (Pubitemid 46239295)
19. Kruk M, Karcz M, Przyluski J et al: White blood cell count adds prognostic information to the thrombolysis in myocardial infarction risk index in patients following primary percutaneous coronary intervention (ANIN Myocardial Infarction Registry). Int J Cardiol, 2007; 116: 376-382 (Pubitemid 46283015)
20. Kruk M, Karcz M, Przyluski J et al: White blood cell count on admission and mortality in patients treated with primary percutaneous coronary intervention. (ANIN Myocardial Infarction Registry). Post Kardiol Interw, 2007; 4: 193-198
21. th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2000; 21-36
22. Schrier RW, Gross P, Gheorghiade M et al: Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med, 2006; 355: 2099-2112 (Pubitemid 44749318)
23. Han DS, Cho BS: Therapeutic approach to hyponatremia. Nephron, 2002; 92(Suppl.1): 9-13